课题基金 / 基金详情

MOLECULAR AND CELL BIOLOGY OF CD36 A TSP RECEPTOR

MOLECULAR AND CELL BIOLOGY OF CD36 A TSP RECEPTOR
CD36 A TSP 受体的分子和细胞生物学
批准号:
2028458
负责人:
Roy L Silverstein
金额:
$23.79万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-07-01 至 2001-07-31

项目摘要

项目成果

Roy L Silverstein的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
CD36 is a multifunctional 88kD transmembrane glycoprotein expressed on platelets, monocytes, macrophages, certain specialized epithelial cells, and adipocytes. It has been shown to function as a cellular receptor for thrombospondin (TSP) and has recently been implicated as a macrophage scavenger receptor for oxidized low density lipoprotein (OxLDL). Oxidation of LDL is strongly linked to the pathogenesis of atherosclerosis in that lipid accumulation in atheromatous plaque results directly from internalization of OxLDL by intimal macrophages. In addition, OxLDL interactions with vascular cells may result in cellular activation to a prothrombotic, proatherogenic phenotype. The central hypothesis of this proposal is that CD36 is a major macrophage receptor for binding and internalizing ligands, including TSP and OxLDL. The focus will be to define the molecular basis of CD36 function and to probe its role in atherosclerosis. Studies in specific aim l will define structure-function relationships that govern CD36 receptor-ligand binding. Interactions with TSP and Oxidized LDL will be studies. These experiments will utilize recombinant CD36 peptides and solid phase and cellular binding studies. Specific aim 2 will define the mechanisms by which human macrophage CD36 internalizes ligands. Regulation of macrophage CD36 mRNA synthesis and surface protein expression in response to mediators of atherogenesis and differentiation will be studied using RNAse protection assays and immunomicroscopy. CD36-mediated internalization pathways and structure-function relationships that govern internalization will also be probed. Aim 3 will evaluate the role of CD36 in monocyte/macrophage biology by developing and studying a murine model genetically engineered so as not to express CD36. Completion of this project will increase understanding of early atherogenic events and allow for the development of novel therapeutic strategies by specific blockade of OxLDL-macrophage interactions. Furthermore, understanding how internalization and intracellular signaling is accomplished by CD36 may lead to broader insight into cellular function. The animal model may also be useful in testing the role of oxidants and anti-oxidants in atherogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanistic Role of CD36 in Thrombosis
  • 批准号:
    8850653
  • 项目类别:
  • 资助金额:
    $4.52万
  • 财政年份:
    2013
  • 负责人:
    Roy L Silverstein
  • 依托单位:
Mechanistic Role of CD36 in Thrombosis
  • 批准号:
    8509398
  • 项目类别:
  • 资助金额:
    $36.89万
  • 财政年份:
    2013
  • 负责人:
    Roy L Silverstein
  • 依托单位:
Mechanistic Role of CD36 in Thrombosis
  • 批准号:
    9068225
  • 项目类别:
  • 资助金额:
    $43.0万
  • 财政年份:
    2013
  • 负责人:
    Roy L Silverstein
  • 依托单位:
Mechanistic Role of CD36 in Thrombosis
  • 批准号:
    8856644
  • 项目类别:
  • 资助金额:
    $42.23万
  • 财政年份:
    2013
  • 负责人:
    Roy L Silverstein
  • 依托单位:
海外基金